February 25, 2009
On Monday, February 23, 2009, Drs. Paul and Joseph Anain, both Vascular surgeons with Sisters Hospital and Catholic Health, were the first surgeons in New York State to implant the “Endurant Stent Graft” in a patient suffering from an abdominal aortic aneurysm. The surgery was a success and the patient will be released from the hospital this week.
Dr. Paul Anain is the first Vascular surgeon in Western New York to participate in the Endurant Stent Graft System clinical trial, sponsored by Medtronic. The stent is designed for Abdominal Aortic Aneurysm patients who are considered especially difficult to treat. The aorta, the body’s main artery, carries blood from the heart to the rest of the body. An aneurysm (bulge or weakening) can form anywhere on the aorta, but is most common in the belly area. If the aneurysm bursts, it can cause serious bleeding and or death.
Sisters Hospital is the only non-university hospital out of 30 facilities in the United States participating in the trial. Physicians at the Cleveland Clinic were the first to start testing the Endurant Stent implant. Dr. Anain is thrilled to be part of such an important national study, “It’s an honor to be working with these other institutions with such big reputations.”
Dr. Anain recently began registering patients in the two-year clinical study. Medtronic will report the findings to the U.S. Food and Drug Administration for final approval.